Abstract:Blanka Wolszczak-Biedrzycka, 1 Justyna Dorf, 2 Joanna Matowicka-Karna, 2 Violetta Dymicka-Piekarska, 2 Marzena Wojewódzka-&Zdotele&zacuteniakowicz, 3 Piotr &Zdotukowski, 4 Anna Zalewska, 5 &Lstrokukasz D&aogonbrowski, 6 Mateusz Maciejczyk 7 1 Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland; 2 Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland; 3 Department of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland; 4 Department of Restorative Dentistry, Croydon University Hospital, London, UK; 5 Independent Laboratory of Experimental Dentistry, Medical University of Bialystok, Bialystok, Poland; 6 Medical Laboratory, "Diagnostyka" Olsztyn, Olsztyn, Poland; 7 Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, Poland Correspondence: Blanka Wolszczak-Biedrzycka, Email Aim: COVID-19 triggers the overproduction of reactive oxygen species (ROS) which, in combination with a weakened antioxidant barrier, can lead to protein oxidation and lipid peroxidation. The aim of this study was to evaluate enzymatic and non-enzymatic antioxidants, the overall redox potential, and protein and lipid peroxidation products in COVID-19 patients, convalescents, and healthy subjects, and to the determine the diagnostic applicability of these parameters in COVID-19 patients. Materials and Methods: The study involved 218 patients with COVID-19, 69 convalescents, and 48 healthy subjects who were selected for the research based on age and sex. The study was conducted between 20 February 2021 and 20 November 2021 in Bia&lstrokystok, Poland. The antioxidant barrier, redox status, and oxidative damage products were assessed in serum/plasma samples with the use of colorimetric and spectrophotometric assays. Results: Glutathione reductase (GR) activity was higher, whereas total antioxidant capacity (TAC) was lower in COVID-19 patients than in convalescents (p< 0.0001) and the control group (p< 0.0001). The concentrations of advanced glycation end products (AGEs), advanced oxidation protein products (AOPP), 4-hydroxynonenal (4-HNE), and malondialdehyde (MDA) were higher in COVID-19 patients (p< 0.0001) and convalescents (p< 0.0001) than in the control group. AGEs were the most effective diagnostic biomarker for differentiating COVID-19 patients from the control group (AUC=0.9971) and convalescents from the control group (AUC=1.000). Conclusion: An infection with the SARS-CoV-2 disrupts the redox balance and increases protein oxidation and lipid peroxidation. AGEs fulfill the criteria for a potential diagnostic biomarker in COVID-19 patients and convalescents. Keywords: oxidative stress, redox biomarkers, antioxidants, COVID-19, SARS CoV-2 virus The pathogenesis of the infection caused by the SARS-CoV-2 has not been fully elucidated to date. The immune response to the infection is complex and highly individualized, which undoubtedly affects the severity of disease symptoms and complications after the infection. 1 Research has shown that severe COVID-19 is not directly caused by the SARS-CoV-2, but by the cytokine storm which increases the production of reactive oxygen species (ROS) that induce oxidative stress. 2 An infection caused by the SARS-CoV-2 leads to the activation of neutrophils and mononuclear phagocytic cells which are largely responsible for the massive release of ROS in lung tissues. 3 In addition, the SARS-CoV-2 reaches lung cells via the angiotensin-converting enzyme 2 (ACE2) receptor, and an imbalance between the rate of ROS production and antioxidant processes may lead to oxidative damage to proteins, lipids, and nucleic acids. 4 Glutathione (GSH) is one of the key components of the antioxidant barrier, and it can prevent the S1 subunit of the SARS-CoV-2 spike protein from binding to the ACE2 receptor in the lungs. 5 According to the literature, an endogenous deficiency of GSH and other antioxidants, including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR), can affect the severity of COVID-19. 6 It is generally known that COVID-19 can lead to post-infection complications and increases the risk of inflammatory, 7,8 metabolic, and neurodegenerative diseases which are also caused by an oxidation-reduction (redox) imbalance. 9 Therefore, oxidative stress parameters and antioxidant levels should be compared in convalesce -Abstract Truncated-

Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity

Systemic redox imbalance in severe COVID‐19 patients

Enhanced Expression of RAGE AXIS Is Associated with Severity of COVID-19 in Patients with Comorbidities

High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID-19 patients: HMGB1 as a biomarker of worst prognosis

Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19

ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases

Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity

Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress

High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients

The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids

High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19

New insights into extracellular and intracellular redox status in COVID-19 patients

Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections

Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19

Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic

Characterization of the Inflammatory Response to Severe COVID-19 Illness

An inflammatory cytokine signature predicts COVID-19 severity and survival

Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-α

Oxidative stress index can be a new marker related to disease severity in COVID-19

Redox Biomarkers – An Effective Tool for Diagnosing COVID-19 Patients and Convalescents

Inflammatory Biomarkers for Assessing In-Hospital Mortality Risk in Severe COVID-19—A Retrospective Study